Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Conceptus cuts outlook for 2Q, year; shares dive

July 8, 2010 3:45 pm | by The Associated Press | News | Comments

Conceptus Inc. cut its second-quarter and full-year forecasts on Thursday, saying the weak economy and high unemployment are causing prospective patients to delay visits to doctors.The company, which makes a non-incisional permanent birth control method, said visits to doctors in the U.S. have...

Reportlinker Adds 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands

July 8, 2010 1:37 pm | by Bio-Medicine.Org | News | Comments

NEW YORK , July 8 /- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment-of-Eye-Care-Medication-Brands.html This study encompasses feedback provided by U.S. physicians on...

TOPICS:

FDA Consumer Health Information: Using Malaria Medication For Leg Cramps Is Risky

July 8, 2010 1:37 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md. , July 8 /PRNewswire-USNewswire/ -- People who use the malaria drug Qualaquin to treat or prevent nighttime leg cramps may want to talk to their health care professional. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:...

TOPICS:
Advertisement

Que She Herbal Supplement: Undeclared Drug Ingredients

July 8, 2010 1:31 pm | by U.S. Food & Drug Administration | News | Comments

Herbal product, sold as weight loss supplement, contains unlisted active pharmaceutical ingredients. Risk of serious side effects, especially in those with heart conditions.

TOPICS:

Conference bursaries make malaria mission possible

July 8, 2010 10:39 am | by EurekAlert | News | Comments

(BioMed Central) Today, BioMed Central announced a fund to help researchers in developing countries attend the conference, Parasite to Prevention. The conference, held in conjunction with Malaria Journal, takes place in Edinburgh UK, Oct. 20-22, 2010.

TOPICS:

University of Manchester academics at international conference on geographic chemicals

July 8, 2010 10:39 am | by EurekAlert | News | Comments

(University of Manchester) A major conference, organized by scientists at the University of Manchester to showcase vital work on the effect of geographic chemicals, begins today.

TOPICS:

Nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk

July 8, 2010 10:39 am | by I-Micronews | News | Comments

Nanotechnology involves the ability to control matter at the scale of a nanometer--one billionth of a meter. The world market for products that contain nanomaterials is expected to reach $2.6 trillion by 2015.

The thinnest, smoothest metallic lines in the world helps speed up miniaturisation of electronic devices

July 8, 2010 10:39 am | by I-Micronews | News | Comments

New method creates super-thin, high integrity, continuous metal lines that surpass today?s semiconductor industry requirements.

Advertisement

Nichia to start sample shipment of green diode laser

July 8, 2010 10:39 am | by I-Micronews | News | Comments

Nichia Corp will finally commercialize its green diode laser for use mainly in pico projectors.

Genzyme to transfer more manufacturing to Hospira

July 8, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Genzyme Corp. is expanding a deal designed to transfer more so-called fill-finish manufacturing work to Hospira Worldwide Inc. – part of an agreement with the U.S. FDA to comply with an enforcement action against the Cambridge-based biotechnology company.

PEAK Surgical Introduces PEAK PlasmaBlade(R) 3.0S

July 8, 2010 10:37 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif. , July 8 /- PEAK Surgical, Inc. today announced the launch of the PEAK PlasmaBlade® 3.0S dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This revolutionary product features a 3.0mm wide blade for even greater cutting...

TOPICS:

Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris

July 8, 2010 10:37 am | by Bio-Medicine.Org | News | Comments

PARIS , July 8, 2010 /- Professor Gerard Saillant , President of the Institute for Brain and Spinal Cord Disorders (ICM), announced today an unprecedented donation of EUR8,000,000 from Mrs. Lily Safra . It is the largest single donation made by a private individual to the ICM. Professor Saillant...

TOPICS:

ECRI Institute Adds 4,000 New Terms to Universal Medical Device Nomenclature Systemâ„¢

July 8, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

Free license gives access to 24,544 terms, including genetic testing and device software PLYMOUTH MEETING, Pa. , July 8 /PRNewswire-USNewswire/ -- ECRI Institute's Universal Medical Device Nomenclature System™,  the most comprehensive medical device taxonomy, announces the...

TOPICS:

Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists

July 8, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

ALBUQUERQUE, N.M. , July 8 /- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP). The CAP is a leading...

TOPICS:

Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactions

July 8, 2010 10:31 am | by U.S. Food & Drug Administration | News | Comments

New Risk Management Plan. Reports of serious side effects in patients using Qualaquin "off-label" for night time leg cramps.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading